- Home
- VIR vs JFR Comparison
VIR vs JFR Comparison
Compare VIR & JFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- JFR
- Stock Information
- Founded
- VIR 2016
- JFR 2004
- Country
- VIR United States
- JFR United States
- Employees
- VIR N/A
- JFR N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- JFR Trusts Except Educational Religious and Charitable
- Sector
- VIR Health Care
- JFR Finance
- Exchange
- VIR Nasdaq
- JFR Nasdaq
- Market Cap
- VIR 1.4B
- JFR 1.1B
- IPO Year
- VIR 2019
- JFR N/A
- Fundamental
- Price
- VIR $7.00
- JFR $8.43
- Analyst Decision
- VIR Buy
- JFR
- Analyst Count
- VIR 6
- JFR 0
- Target Price
- VIR $35.67
- JFR N/A
- AVG Volume (30 Days)
- VIR 1.1M
- JFR 621.7K
- Earning Date
- VIR 05-01-2025
- JFR 01-01-0001
- Dividend Yield
- VIR N/A
- JFR 11.31%
- EPS Growth
- VIR N/A
- JFR N/A
- EPS
- VIR N/A
- JFR N/A
- Revenue
- VIR $74,205,000.00
- JFR N/A
- Revenue This Year
- VIR N/A
- JFR N/A
- Revenue Next Year
- VIR $17.69
- JFR N/A
- P/E Ratio
- VIR N/A
- JFR N/A
- Revenue Growth
- VIR N/A
- JFR N/A
- 52 Week Low
- VIR $6.56
- JFR $7.61
- 52 Week High
- VIR $14.45
- JFR $8.82
- Technical
- Relative Strength Index (RSI)
- VIR 28.28
- JFR 38.84
- Support Level
- VIR $6.96
- JFR $8.41
- Resistance Level
- VIR $7.46
- JFR $8.53
- Average True Range (ATR)
- VIR 0.57
- JFR 0.07
- MACD
- VIR -0.16
- JFR 0.00
- Stochastic Oscillator
- VIR 1.56
- JFR 12.94
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About JFR Nuveen Floating Rate Income Fund
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income, consistent with the preservation of capital. It invests in adjustable-rate U.S. dollar-denominated secured Senior Loans.